Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Gorlia, T.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(21 - 27 of 27)

Pages

MEMORY FUNCTIONING IN LOW-GRADE GLIOMA PATIENTS TREATED WITH EITHER RADIOTHERAPY (RT) OR TEMOZOLOMIDE (TMZ) CHEMOTHERAPY. A CORRELATIVE ANALYSIS OF EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT (EORTC) STUDY 22033-26033
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
STABILITY OF ACTIONABLE MUTATIONS IN PRIMARY AND RECURRENT GLIOBLASTOMAS
FIRST RESULTS OF THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1P/19Q INTACT 1ST RECURRENCE GRADE II AND III GLIOMA
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas

Pages